Proscia: Reflections on KLAS’ US Digital Pathology Report: What it Means to Be a Long-Term Partner
recent articles
Indica Labs: Learn about the exciting new features in the 2.5 versions of HALO AP®! HALO AP 2.5 Sneak Peek Webinar Date: 16 April 2026 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00...
Aiforia: AI model development used to be a marathon of data and time, but we have built a shortcut. Join Aiforia’s CPO and Director of Software Development to discover how Aiforia’s Foundation Engine elevates your research and...
CorePlus and Ibex: Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further enhance diagnostic precision. CAROLINA, Puerto Rico & BOSTON--(BUSINESS...
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast...
Lunit, CellCarta: Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence generation and CDx launch...
Lumea: IMS Viewer+ (FDA-cleared and CE-marked under IVDR) now seamlessly incorporates Cleo Skin, Primaa’s AI solution, into dermpaths' digital workflows. LEHI, UT, UNITED STATES, March 24, 2026 /EINPresswire.com/ -- Lumea, the U.S. leader in...
